Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.846310
Abstract: Multiple myeloma is an incurable plasma B-cell malignancy with 5-year survival rates approximately 10-30% lower than other hematologic cancers. Treatment options include combination chemotherapy followed by autologous stem cell transplantation. However, not all patients are… read more here.
Keywords: targeting chemokine; chemokine receptor; myeloma; multiple myeloma ... See more keywords